Finding studies
Finding studies
Take this into the appointment.
Saves the questions and what to expect into your notes, next to the visit they belong to.
Study Contact
CONTACT
Lead
Intra-Cellular Therapies, Inc.
The study will be conducted in 3 phases: * Screening Period (up to 2 weeks) during which patient eligibility will be assessed * Double-blind Treatment Period (6 weeks) during which all patients will be randomized to receive lumateperone or placebo in 1:1 ratio. * Safety Follow-up Period (1 week) during which all patients will return to the clinic for a safety follow-up (SFU) visit approximately one week after the last dose of study drug.
Age
10–17
Sex
ALL
Healthy volunteers
Not accepted